Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2007-02-13 Investor Presentation
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Bio CEO & Investor Conference 2007New York Feb 13th, 2007
Investor Presentation
2007-02-13 English
Q3 Report 2006
Interim / Quarterly Report
2006-10-27 English
Q3 Bericht 2006
Interim / Quarterly Report
2006-10-27 German
Mitteilung uber Geschafte von Fuhrungspersonen nach 15a WpHG
Director's Dealing Classification · 100% confidence The document text explicitly contains the header "Directors’ Dealings" and the German equivalent "Mitteilung über Geschäfte von Führungspersonen nach §15a WpHG". It details a transaction (sale of shares) by a member of the management board ("Funktion: Geschäftsführendes Organ"). This directly corresponds to the definition of Director's Dealing reports.
2006-10-13 German
Mitteilung uber Geschafte von Fuhrungspersonen nach 15a WpHG
Director's Dealing Classification · 100% confidence The document is titled 'Directors’ Dealings' and explicitly states 'Mitteilung über Geschäfte von Führungspersonen nach §15a WpHG' (Notification about transactions by persons discharging managerial responsibilities according to §15a WpHG). It details a transaction (sale of shares) by an individual named Simon Moroney, who is part of the 'Geschäftsführendes Organ' (Managing Body). This content directly corresponds to the definition of Director's Dealing reports, which track personal share transactions by directors and executives. Therefore, the correct classification is DIRS.
2006-09-29 German
Mitteilung uber Geschafte von Fuhrungspersonen nach 15a WpHG
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains the German regulatory header 'Mitteilung über Geschäfte von Führungspersonen nach §15a WpHG' (Notification of transactions by persons discharging managerial responsibilities pursuant to Section 15a WpHG). It details a 'Verkauf' (Sale) transaction by a director ('Sproll, Dr. Marlies') involving company shares, including the date, price, and volume. This directly corresponds to the definition of Director's Dealing.
2006-08-21 German

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.